NPPA fixes price of 21 formulations including diabetes drugs, others; Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed prices of 21 formulations.
These include some popular drug brands like Rabishield –50, Valera M 1000 Tablet, Panlactic 375, VILDOV M 1000, Valdepain M 850 and others. The formulations mentioned in the list are combination drugs indicated for the treatment of diabetes, rabies infection and others.
The drugs mentioned in the recently released NPPA list are manufactured by prominent drugmakers including Zydus Healthcare, Akums Labs, Alkem Health sciences, Eris Lifesciences, Mylan, Hetero Labs and others.
In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Paclitaxel + Human Albumin Injection (Paclitaxel Protein Bound Particles for Injectable suspension 100mg) | Paclitaxel Protein Bound Particles for Injectable suspension 100mg Each Lyophilized vial contains: Paclitaxel IP 100mg Human Albumin IP 900mg per 20ml |
Each Pack |
M/s SPAL Private Limited / M/s Intas Pharmaceuticals Pvt. Ltd. | 4795.27 |
| 2. | Calcium + Vitamin D3 + Methylcobalamin + Pyridoxine + Folic Acid Tablet | Each film coated tablet contains: Calcium Citrate USP 1000mg, Vitamin D3 200IU, Methylcobalamin IP 500mcg, Pyridoxine HCI IP 10mg, Folic Acid IP 5mg, |
1 Tablet |
M/s Mascot Health Series Pvt. Ltd. / M/s Zydus Healthcare Limited | 11.48 |
| 3. | Vildagliptin + Metformin Tablet (INSUVIL-M) | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Pure & Cure Healthcare (P) Ltd. / M/s Anthus Pharmaceuticals Pvt. Ltd. | 6.14 |
| 4. | Vildagliptin + Metformin Tablet | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. | 6.14 |
| 5. | Vildagliptin + Metformin Tablet | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Eris Lifesciences Limited / M/s Aprica Healthcare Pvt. Ltd. | 6.14 |
| 6. | Vildagliptin + Metformin Tablet (VILDOV M 500) | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Hetero Labs Limited / M/s Hetero Healthcare Limited | 6.14 |
| 7. | Vildagliptin + Metformin Tablet (Valdepain M 500) | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Innova Captab Ltd. / M/s Galpha Laboratories Limited | 6.14 |
| 8. | Vildagliptin + Metformin Tablet (Vilason M 500) | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Unison Pharmaceuticals Pvt. Ltd. | 6.07 |
| 9. | Vildagliptin + Metformin Tablet | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 850mg, | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. | 6.24 |
| 10. | Vildagliptin + Metformin Tablet | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 850mg, | 1 Tablet | M/s Eris Lifesciences Limited / M/s Aprica Healthcare Pvt. Ltd. | 6.24 |
| 11. | Vildagliptin + Metformin Tablet (Valdepain M 850) | Each film coated tablet contains: Vildagliptin 50mg,
Metformin Hydrochloride IP 850mg, | 1 Tablet | M/s Innova Captab Ltd. / M/s Galpha Laboratories Limited | 6.24 |
| 12. | Vildagliptin + Metformin Tablet | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 1000mg, | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. | 6.36 |
| 13. | Vildagliptin + Metformin Tablet | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 1000mg, | 1 Tablet | M/s Eris Lifesciences Limited / M/s Aprica Healthcare Pvt. Ltd. | 6.36 |
| 14. | Vildagliptin + Metformin Tablet (VILDOV M 1000) | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 1000mg, | 1 Tablet | M/s Hetero Labs Limited / M/s Hetero Healthcare Limited | 6.36 |
| 15. | Vildagliptin + Metformin Tablet (Valdepain M 1000) | Each film coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 1000mg, | 1 Tablet | M/s Innova Captab Ltd. / M/s Galpha Laboratories Limited | 6.36 |
| 16. | Amoxycillin + Potassium Clavulanate Tablet (Panlactic 1000) | Each film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 875mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg, | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Mylan Pharmaceuticals Private Limited | 28.00 |
| 17. | Amoxycillin + Potassium Clavulanate Tablet (Panlactic 375) | Each film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg, | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Mylan Pharmaceuticals Private Limited | 15.15 |
| 18. | Rabies Human Monoclonal Antibody Injection (Rabishield – 50) | Each ml injection contains: Rabies Human Monoclonal Antibody (rDNA) 40IU (50IU/1.25ml) | Each pack of 1.25ml |
M/s Serum Institute of India Pvt. Ltd. | 856.65 |
| 19. | Amoxicillin + Cloxacillin + Lactic Acid Bacillus Capsule | Each hard gelatine capsule contains: Amoxicillin Trihydrate IP eq. to Amoxicillin 250mg, Cloxacillin Sodium IP eq. to Cloxacillin 250mg, Lactic Acid Bacillus 2 billion spore | 1 Capsule | M/s Skymap Pharmaceuticals Pvt. Ltd. | 3.54 |
| 20. | Metformin Hydrochloride + Evogliptin Tablet (Valera M 1000 Tablet) | Each film coated bilayered Tablet contains: Metformin Hydrochloride IP 1000mg (Sustained Release), Evogliptin Tartrate 6.869mg eq. to Evogliptin 5mg Tablet |
1 Tablet |
M/s Alkem Healthscience / M/s Alkem Laboratories Ltd. | 18.44 |
| 21. | Paracetamol + Caffeine Tablet (SARBYNA STRONG) | Each uncoated tablets contains: Paracetamol IP 500mg Caffeine Anhydrous IP 50mg |
1 Tablet | M/s Rivpra Formulation Pvt. Ltd. / M/s Dabur India Ltd | 1.25 |
Also Read: NPPA Fixes Price Of 17 Formulations Including BP Drugs, Painkillers; Details
The notice further added;
(a) The manufacturer of above-mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
For more details check out the notice below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd